Airway Disease Articles & Analysis
10 news found
Asthma remains a complex and multifactorial disease, with airway hyperresponsiveness to methacholine being a hallmark feature. ...
These latest imaging biomarkers strengthen VIDA’s portfolio of airway, tissue, vascular and functional measures. VIDA’s latest airway biomarkers include mucus plug scoring, bronchiectasis scoring, and total airway count (TAC). ...
About Atectura® Breezhaler® Atectura® Breezhaler® is indicated as a once-daily maintenance treatment of asthma in adults and adolescents 12 years of age and older with reversible obstructive airways disease. Atectura® Breezhaler® should be prescribed for patients not adequately controlled on a long-term asthma control medication, such as ...
About Atectura® Breezhaler® Atectura® Breezhaler® is indicated as a once-daily maintenance treatment of asthma in adults and adolescents 12 years of age and older with reversible obstructive airways disease. Atectura® Breezhaler® should be prescribed for patients not adequately controlled on a long-term asthma control medication, such ...
The role of spirometry in diagnosing and monitoring chronic obstructive airway diseases is crucial. According to WHO, the demonstration of irreversible airway obstruction is essential for diagnosing chronic obstructive pulmonary disease (COPD), which is the third leading cause of death worldwide. ...
ByAioCare
Stemedica’s Licensing Agreement with Pulthera is for the diagnosis, prevention and/or treatment of COVID-19 and complications thereof and for lung, pulmonary and respiratory conditions including, but not limited to, ARDS, Asthma, Bronchitis, COPD, Cystic Fibrosis, Emphysema, Pleural Effusion, Pneumonia, Pulmonary Fibrosis, and Reactive Airway Disease on a ...
This Summit is a yearly event held in advance of the American Thoracic Society’s International meeting which brings together clinicians, innovators and investors focused on new approaches for treating widespread and crippling lung and airway diseases. “This is an ideal venue for highlighting the clinical progress made in establishing our ...
Mucus and other airway secretions surrounding influenza viruses when coughed or exhaled from infected individuals may protect the virus in the aerosol phase, even in high humidity environments. ...
The article stated, “…researchers suspect that it's the diversity of exposure to different microbes that may offer protection against the airway disease.” The Centers for Disease Control and Prevention (CDC) reports, “Asthma is a disease that affects your lungs. ...
In February of this year it was reported in HealthDay News that, “The risk of asthma was reduced by as much as 51 percent for children living on farms, and researchers suspect that it's the diversity of exposure to different microbes that may offer protection against the airway disease.” Asthma attacks create an inflammation of the lungs and ...